World Health Organization Issues Alert Over Acute Lack of Weight-Loss Injections
Fewer than 10% of patients eligible to benefit from weight-loss injections such as Wegovy can access them, caution the World Health Organization as it releases its first recommendations on the drugs.
With more than one billion individuals worldwide now obese, it is calling for broader and more equitable availability to these injectable treatments.
Per projections, over two billion could be obese by 2030 unless action is taken.
"The latest guidelines acknowledges that obesity is a long-term condition that can be treated with holistic and ongoing care," stated the agency's head Tedros Adhanom Ghebreyesus.
High costs, limited production capacity, and distribution challenges are significant hurdles to universal availability to the injections that can aid individuals in losing considerable body mass, notes the organization.
Skinny Jab Supply Crisis
Even in the current most optimistic outlook, the manufacturing of these medications would only suffice for around 100 million people – fewer than 10% of those who need them, according to the health organization.
The guideline urges governments and firms to increase availability, through approaches including licensing agreements.
A patent on a key compound – the primary component of a leading brand – is scheduled to end in several countries in 2026.
The Way Weight-Loss Jabs Work
These medications mimick a body's own hormone to reduce digestion speed, reduce hunger and enhance satiety so users consume fewer calories.
Patients typically see weight reduction after several weeks of beginning the once-weekly jabs.
Evidence points to patients may put most of the weight back on after a year of discontinuing the medication, as their usual food cravings come back.
Being above a healthy weight increases your likelihood for contracting diseases, like type 2 diabetes, heart disease, stroke, and specific malignancies.
Excess weight concerns people in every country and was responsible for millions of deaths worldwide in 2024, as per the WHO.